Key statistics
As of last trade WAVE Life Sciences Ltd (1U5:DEU) traded at 7.65, -13.56% below its 52-week high of 8.85, set on Sep 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 7.80 |
---|---|
High | 7.90 |
Low | 7.50 |
Bid | 7.65 |
Offer | 7.75 |
Previous close | 7.80 |
Average volume | 1.48k |
---|---|
Shares outstanding | 145.60m |
Free float | 122.54m |
P/E (TTM) | -- |
Market cap | 1.22bn USD |
EPS (TTM) | -0.5796 USD |
Data delayed at least 15 minutes, as of Oct 04 2024.
More ▼
Announcements
- Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
- Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
- Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
- Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping
- Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
- Wave Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business Update
- Wave Life Sciences Second Quarter 2024 Financial Results Scheduled for August 8, 2024
- Wave Life Sciences Announces Positive Results from Phase 1b/2a SELECT-HD Trial with First Clinical Demonstration of Allele-Selective Mutant Huntingtin Lowering in Huntington’s Disease
- Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA Editing
More ▼